Navigation Links
Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding
Date:11/1/2010

INDIANAPOLIS, Nov. 1, 2010 /PRNewswire/ -- More than half of the life sciences start-up companies in the BioCrossroads-managed Indiana Seed Fund portfolio have received notices of funding through the Therapeutic Discovery Project Credit under the federal Patient Protection and Affordable Care Act of 2010.

Seed Fund companies AgeneBio, CS-Keys, FAST, GRest, Pericardial Access and SonarMed all learned today from the Internal Revenue Service of their certification for a qualified investment via this federal tax credit program.

"It's a great day for Indiana's entrepreneurs and some of our most promising therapies and medical devices.  With a federal government short on funds and an economy tight on capital, this is a significant amount of funding that will add some very timely fuel to some of our most important development efforts," said David Johnson, president and CEO of BioCrossroads.  "It's also interesting confirmation, from a credible if somewhat unusual source, that our Indiana Seed Fund is a good judge of breakthrough innovation when it comes to start-ups for advancing novel drug, device or diagnostic products."

The IRS called for applications for funding during June and July 2010 for innovative diagnostic projects as well as projects that develop a novel product, process, or technology to further the effective delivery or administration of innovative therapeutics.

About BioCrossroads

BioCrossroads (www.biocrossroads.com) is Indiana's initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region's research and corporate strengths while encouraging new business development.   BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX,  Datalys Center and OrthoWorx) expands collaboration and partnerships among Indiana's life science institutions, promotes science education and markets Indiana's life sciences industry.


'/>"/>
SOURCE BioCrossroads
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
2. Public Art to Complete Transformation of Key Gateway into Indianapolis
3. Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services
4. Total Federal Grant Funds for Indiana Health Information Technology Efforts Climb to Nearly $50 Million; Latest $16 Million Installment Spotlights Indiana Health Information Exchange in Delivering Higher Quality and Higher Value Healthcare Through M
5. Hill-Rom to Present at the INVESTIndiana Investor Conference
6. Zimmer Holdings to Present at INVESTIndiana Equity Conference
7. Indiana State Legislators Seek Solutions to Combat Illegal Meth Production
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
11. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. ... will create 1,400 jobs throughout Western New ... partnership with the SUNY Polytechnic Institute, includes a major ... Building in Buffalo , as well ... manufacturing facility in Dunkirk . The ...
(Date:2/11/2016)... WILMINGTON, N.C. , Feb. 11, 2016 /PRNewswire/ ... a leading provider of custom manufacturing and development ... announces expanded sterile fill-finish capabilities and capacity in ... Substantial growth in demand has driven several recent ... in 2001 it had one filling line with ...
(Date:2/11/2016)... Iowa , Feb. 11, 2016  Proliant Biologicals ... Zealand Bovine Serum Albumin (BSA) manufacturing facility.  The facility ... New Zealand , in Feilding. ... was done to functionally duplicate the systems in the ... same vendors used for U.S. installations.  --> ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... , ... According to an article published February 1st on Consumer ... is being recalled due to the discovery that it contains dangerous adulterants. According to ... supplement on the market proven to help people safety lose excess weight, such cases ...
(Date:2/11/2016)... ... February 11, 2016 , ... Florida Hospital presents Heart Health Awareness night ... Louis Blues at the Amalie Arena. The puck drops at 6:00pm, but fans will ... MEGA Heart, prior to the game. The MEGA Heart will be located on Ford ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... reverse diabetes has been gearing up for their simultaneous grand openings in March. ... about right now that you’re probably wondering, is reversing diabetes possible? According to ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical ... technology, with highly adaptable algorithms, has been updated to help Emergency Department physicians ... symptoms consistent with Zikas and a travel history to affected regions, or potential ...
(Date:2/11/2016)... Orange City, FL (PRWEB) , ... February 11, ... ... has announced the commencement of a master charity program created to assist the ... every 60 days, working closely with nonprofit organizations and community leaders. Their hope ...
Breaking Medicine News(10 mins):